Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 1st September 2022
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

PPID quality of life tool to be developed
Pituitary Pars Intermedia Dysfunction can cause laminitis.
RVC to undertake three-year project.

Researchers from the Royal Veterinary College (RVC) have announced a project to develop a new tool to assess the quality of life of horses and ponies with Pituitary Pars Intermedia Dysfunction (PPID).

A hormone disorder that affects the pituitary gland of horses, PPID often causes the animals to develop laminitis, leading to extreme pain, instability of the pedal bone within the hoof capsule and in some cases, euthanasia. 

As well as these, PPID can also cause weight loss, behavioural changes and lethargy. 

Owing to the potential negative impact of PPID symptoms on an equine's quality of life, researchers are will develop an assessment tool to assist veterinary professionals and equine owners in making informed decisions about care.

Professor Nicola Menzies-Gow, of the RVC, said: “This is an exciting project that will hopefully allow development of a tool that can be used to objectively assess the quality of life of horses and ponies with PPID and determine which aspects of the disease and its treatment have the greatest impact on this.”

Set to be developed over the course of three years, the tool will be created first by interviewing equine veterinary surgeons and owners of equines with PPID to ascertain which aspects of the disorder appear to impact quality of life the most.

The data and information gathered from this will be used to develop a questionnaire for a larger number of horse owners, and following this, the question-based tool will be created.

For the remaining two years of the study, the tool will be used to assess 140 horses and ponies newly diagnosed with PPID. These equines will be followed over the two-year period to see how quality of life is impacted, and whether the drug pergolide improves this. 

Ultimately, the study aims to determine the effect of pergolide on the quality of life of equines diagnosed with PPID, and to assist veterinary professionals and owners in decision-making regarding treatments or euthanasia. 

The research will be led by Nicola Menzies-Gow, Professor of Equine Medicine at the RVC, Christine Nicol, Professor of Animal Welfare at the RVC, Dr Edd Knowles and Dr Imogen Schofield from CVS.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.